Chinese Journal of Pharmacovigilance ›› 2024, Vol. 21 ›› Issue (5): 489-495.
DOI: 10.19803/j.1672-8629.20240143
Previous Articles Next Articles
LIU Tianrui1,2,3, LI Yao1,2, CHEN Yuxin1,2, LI Hui1,2, GAO Haiyun1,2, YUAN Yuan1,2,3,*
Received:
2024-02-29
Online:
2024-05-15
Published:
2024-05-13
CLC Number:
LIU Tianrui, LI Yao, CHEN Yuxin, LI Hui, GAO Haiyun, YUAN Yuan. Toxicity analysis and safe application of 7 common fungi prone to adverse reactions[J]. Chinese Journal of Pharmacovigilance, 2024, 21(5): 489-495.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgywjj.com/EN/10.19803/j.1672-8629.20240143
[1] LIU R.Preliminary investigation and exploration of development and utilization of large fungal resources in Xinglongshan national nature reserve, Gansu province[J]. Contemporary Horticulture(现代园艺), 2024, 47(2): 15-17, 28. [2] YANG ZL, WU G, LI YC, et al.Common Edible and Poisonous Mushrooms of Southwestern China(中国西南地区常见食用菌和毒菌)[M]. Beijing: Science Press, 2021. [3] DAI YC.New trends in the research and development of edible and medicinal fungi in China: analysis of papers published in Chinese Journal of Fungi from 2000 to 2021[J]. Microbiol Research(菌物研究), 2022, 20(2): 141-156. [4] LI HJ, ZHANG YZ, LIU ZT, et al.Species diversity of poisonous mushrooms in mushroom poisoning events in Yunnan province[J]. Mycosystema(菌物学报), 2022, 41(9): 1416-1429. [5] YANG ZL, WU G, LI YC.Mushrooms of Yunnan(云南野生菌)[M]. Beijing: Science Press, 2022. [6] WU Y, DU JX, ZHANG J, et al.Analysis of bacterial diversity in shiroes soil of Boletus magnificus by high-throughput sequencing[J]. Edible Fungi of China(中国食用菌), 2021, 40(1): 84-90. [7] ZHANG Y.Principle of inhibition of motor nervous system by alkaloids of Boletus parviflora[J]. Edible Fungi of China(中国食用菌), 2020, 39(3): 41-43. [8] WU F, ZHOU LW, YANG ZL, et al.Resource diversity of Chinese macrofungi: edible, medicinal and poisonous species[J]. Fungal Diversity, 2019, 98(1): 1-76. [9] LI JP, ZHONG JJ, YAO QM, et al.Clinical characteristics analysis of 36 cases of hallucinogenic boletus poisoning[J]. Chinese Journal of Nervous and Mental Diseases(中国神经精神疾病杂志), 2023, 49(10): 577-583. [10] LI Y, LI HJ, FU YS, et al.Analysis of epidemiology and clinical characteristics of Lanmaoa asiatica poisoning[J]. Journal of Clinical Emergency(临床急诊杂志), 2023, 24(5): 258-261, 265. [11] DAI RX, MENG Q, CHEN GB.Research progress of neuropsychiatric poisonous mushrooms and their toxins[J]. Chinese Journal of Nervous and Mental Diseases(中国神经精神疾病杂志), 2022, 48(8): 493-497. [12] SONG SF.Patients were admitted to ICU after eating red onion online shopping[J]. China Food Industry(中国食品工业), 2022(13): 82-83. [13] SANG HZ, XIE Y, SU X, et al.Mushroom Bulgaria inquinans modulates host immunological response and gut microbiota in mice[J]. Frontiers in Nutrition, 2020, 7: 144. [14] SHEN SJ, FENG ZY, JIANG SJ, et al.Azaphilones from the fungus Penicillium multicolor LZUC-S2 and their antibacterial activity[J]. Chemistry & Biodiversity, 2023, 20(3): e202201180. [15] HAN H.Antimalarial activity of Ginseng polysaccharides and Bulgaria Inauinans polysaccharides[D]. Changchun: Northeast Normal University(东北师范大学), 2008. [16] BI H, HAN H, LI Z, et al.A water-soluble polysaccharide from the fruit bodies of Bulgaria inquinans (fries) and its anti-malarial activity[J]. Evidence-Based Complementary and Alternative Medicine, 2011, 2011: 973460. [17] SANG HZ.Effects of Bulgaria Inquinans on murine immune functions and gut microbiota[D]. Zhengzhou: Henan University, 2021. [18] JIANG S, TSUMURO T, TAKUBO M, et al.Antipruritic and antierythema effects of ascomycete Bulgaria inquinans extract in ICR mice[J]. Biological & Pharmaceutical Bulletin, 2005, 28(12): 2197-2200. [19] JIAO LH, WANG FL, MA YP, et al.Research progress on molecular biology of Auricularia heimuer[J]. Northern Horticulture(北方园艺), 2023(17): 124-129. [20] ZHANG ZX.Research progress on action and application of main biological activities of Auricularia auricular[J]. Edible and Medicinal Mushrooms(食药用菌), 2022, 30(1): 20-25. [21] ZHANG HY, ZHAO SJ, LI H, et al.Bioactive substances of Auricularia auricularia and its processing status in food industry[J]. Modern Agricultural Science and Technology(现代农业科技), 2023(1): 173-180. [22] YANG GL. What are the hazards of soaking Auricularia auricula for a long time[N]. China Science Daily, 2015-07-15(8). [23] LI ZJ, BAO HY.Correlation between different soaking way and content of diisobutyl phthalate in Auricularia heimuer[J]. Mycosystema(菌物学报), 2018, 37(3): 389-394. [24] SEUNG HJ, JI HJ, HEA YC, et al.Toxicokinetic studies of di-isobutyl phthalate focusing on the exploration of gender differences in rats[J]. Chemosphere, 2022, 286(P1): 131706. [25] KIM SM, KIM YH, HAN GU, et al.Diisobutyl phthalate (DiBP)-induced male germ cell toxicity and its alleviation approach[J]. Food and Chemical Toxicology, 2024, 184: 114387. [26] PEI CX, LI Z, ZHANG YM, et al.Effect of PAEs on IL-4 production in primary lymphocyte[J]. Journal of Shenyang Medical College(沈阳医学院学报), 2009, 11(2): 77-78, 90. [27] ZHU C, SUN Y, ZHAO Y, et al.Associations between Children's asthma and allergic symptoms and phthalates in dust in metropolitan Tianjin, China[J]. Chemosphere, 2022, 302: 134786. [28] DENG WQ, XIAO ZR, LI P, et al.Purification of toxins from Amanita exitialis and their anti-tumor effects in vitro[J]. Acta Edulis Fungi(食用菌学报), 2012, 19(4): 71-78. [29] TIZIANA V, NICOLETTA V, MATILDE M, et al.Anti-CD37 alpha-amanitin conjugated antibodies as potential therapeutic weapons for Richter's syndrome[J]. Blood, 2022, 140(13):1565-1569. [30] CHU JZ, CUI Q, YANG SD, et al.Research progress on toxicity mechanism of mushroom toxins[J]. Chinese Traditional and Herbal Drugs(中草药), 2022, 53(24): 7925-7932. [31] ZAVADINACK M, DE LBD, DA RBJL, et al.An α-D-galactan and a β-D-glucan from the mushroom Amanita muscaria: structural characterization and antitumor activity against melanoma[J]. Carbohydrate Polymers, 2021, 274(15): 118647. [32] KONDEVA B, VOYNOVA M, SHKONDROV A, et al.Effects of Amanita muscaria extract on different in vitro neurotoxicity models at sub-cellular and cellular levels[J]. Food and Chemical Toxicology, 2019, 132: 110687. [33] LI YH, HSU DZ, LIU CT, et al.The protective effect of muscimol against systemic inflammatory response in endotoxemic mice is independent of GABAergic and cholinergic receptors[J]. Canadian Journal of Physiology and Pharmacology, 2022, 100(7): 665-678. [34] JOHNSTON GA.Muscimol as an ionotropic GABA receptor agonist[J]. Neurochemical Research, 2014, 39(10): 1942-1947. [35] STEBELSKA K.Fungal hallucinogens psilocin, ibotenic acid, and muscimol: analytical methods and biologic activities[J]. Therapeutic Drug Monitoring, 2013, 35(4): 420-442. [36] VOYNOVA M, SHKONDROV A, BURDINA KM, et al.Toxicological and pharmacological profile of Amanita muscaria (L.) Lam.-a new rising opportunity for biomedicine[J]. Pharmacia, 2020, 67(4): 317-323. [37] QUENTIN C, MICHEL L.Amanita muscaria: ecology, chemistry, myths[J]. Encyclopedia, 2021, 1(3): 905-914. [38] MICHELOT D, MELENDEZ-HOWELL LM.Amanita muscaria: chemistry, biology, toxicology, and ethnomycology[J]. Mycological Research, 2003, 107(Pt2): 131-146. [39] HU YP, ZHANG JX, ZHAO LQ, et al.Physicochemical property and antioxidant activity of polysaccharide from Gymnopilus spectabilis[J]. Natural Product Research and Development(天然产物研究与开发), 2018, 30(2): 274-279. [40] HU YP, LIN LH, LI N, et al. Study on antioxidation and anti diabetes mechanism of polysaccharides from several edible and medicinal fungi[EB/OL]. (2021-11-16)[2024-04-14]. https://kns-cnki-net-443.webvpn.wzu.edu.cn/kcms2/article/abstract?v=6zqdfgkTh_rWPOVFx9SQoojQiBvHLCA6AoWbLna0egJziFc1R0m79HU5gY5AdnKrNNlVfQd52QjIEVZmREf2nePAKjHyD-M7i7yQrm_9D1KzF09hq8ywyNHHpakRhEUw5UlQQZgWXKagpZMoCOQz2A==uniplatform=NZKPTlanguage=CHS. [41] CHEN JB.Study on biological characteristics,chemical compositions and anti-tumor effect of Gymnopilus spectabilis[D]. Changchun: Jilin Agricultural University(吉林农业大学), 2008. [42] BAO HY, LI Y.Studies on inhibition of the extract from Gymnopilus spectabilis to MCF-7[J]. Journal of Jilin Agricultural University(吉林农业大学学报), 2002(2): 56-58. [43] TANAKA M, HASHIMOTO K, OKUNO T, et al.Neurotoxic oligoisoprenoids of the hallucinogenic mushroom, Gymnopilus spectabilis[J]. Phytochemistry, 1993, 34(3): 661-664. [44] XUE RX, LIU GP, QIU BF, et al.Determination of 5 neuropsychiatric mushroom toxins in wild fungi by ultra high performance liquid chromatography-tandem mass spectrometry[J]. Chinese Journal of Industrial Medicine(中国工业医学杂志), 2024, 37(1): 96-99. [45] AOYAGI F, MAENO S, OKUNO T, et al.Gymnopilins, bitter principles of the big-laughter mushroom Gymnopilus spectabilis[J].Tetrahedron Letters, 1983, 24(19): 1991-1994. [46] SHUNSUKE M, NAOKI K, AIKO N, et al.Gymnopilin-a substance produced by the hallucinogenic mushroom, Gymnopilus junonius-mobilizes intracellular Ca2+ in dorsal root ganglion cells[J]. Biomedical Research, 2012, 33(2): 111-118. [47] KAYANO T, KITAMURA N, MIYAZAKI S, et al.Gymnopilins, a product of a hallucinogenic mushroom, inhibit the nicotinic acetylcholine receptor[J]. Toxicon, 2014, 81: 23-31. [48] NISHIO A, KITAMURA N, TANAKA S, et al.Multiple effects of gymnopilin on circulatory system of the rat[J]. Biological & Pharmaceutical Bulletin, 2012, 35(8): 1300-1305. [49] YANG L, XIANG P, DANG YH, et al.Advances in analytical methods of psilocin and psilocybin[J]. Chinese Journal of Forensic Science(中国司法鉴定), 2021(2): 24-32. [50] SHARMA P, NGUYEN QA, MATTHEWS SJ, et al.Psilocybin history, action and reaction: a narrative clinical review[J]. Journal of Psychopharmacology, 2023, 37(9): 849-865. [51] GABLE RS.Comparison of acute lethal toxicity of commonly abused psychoactive substances[J]. Addiction, 2004, 99(6): 686-696. [52] WATFORD T, MASOOD N.Psilocybin, an effective treatment for major depressive disorder in adults-a systematic review[J]. Clinical Psychopharmacology and Neuroscience, 2024, 22(1): 2-12. [53] ZHANG YP, LIN XY.A case of food poisoning caused by Gymnopilus spectabilis[J]. Hunan Medicine(湖南医学), 1989, 6(3): 187. [54] GAO Z.Characterization and mechanism on renovating diabetic nephropathic of mycelia polysaccharides from Coprinus comatus[D]. Jinan: Shandong agricultural university, 2022. [55] ZHENG Z, QU H, ZHOU H, et al.Changes in quality, ultrastructure, reactive oxygen species and cell wall metabolisms of postharvest Coprinus comatus stored at different temperatures[J]. Scientia Horticulturae, 2022, 298: 110989. [56] FAJAR H, HERNAYANTI H, NURAENI E, et al.Antidiabetic effects and antioxidant properties of the saggy ink cap medicinal mushroom, Coprinus comatus (agaricomycetes), in streptozotocin-induced hyperglycemic rats[J]. International Journal of Medicinal Mushrooms, 2021, 23(10): 9-21. [57] GU DY, TANG SS, LIU C, et al.Optimization of liquid fermentation conditions for Coprinus comatus to enhance antioxidant activity[J/OL]. Preparative Biochemistry Biotechnology, [2024-02-28].https://pubmed.ncbi.nlm.nih.gov/38147976/. [58] PATRYK N, RENATA M, KRYSTYNA G, et al.Mushrooms as potential therapeutic agents in the treatment of cancer: evaluation of anti-glioma effects of Coprinus comatus, Cantharellus cibarius, Lycoperdon perlatum and Lactarius deliciosus extracts[J]. Biomedicine Pharmacotherapy, 2021, 133: 111090. [59] YU JY, SUN JG, SUN M, et al.Protective mechanism of Coprinus comatus polysaccharide on acute alcoholic liver injury in mice, the metabolomics and gut microbiota investigation[J]. Food Science and Human Wellness, 2024, 13(1): 401-413. [60] LINDBERG P, BERGMAN R, WICKBERG B, et al.Isolation and structure of coprine, a novel physiologically active cyclopropanone derivative from Coprinus atramentarius and its synthesis via 1-aminocyclopropanol[J].Journal of the Chemical Society, 1975: 946. [61] QIN Q, BAO HY, YAN F, et al.The toxicity and renal injury mechanism of disulfiram like reaction induced by Coprinus comatus[J]. Acta Edulis Fungi(食用菌学报), 2021, 28(6): 98-108. [62] PATRYK N, SYLWIA KN, RENATA M, et al.The two faces of Coprinus comatus-functional properties and potential hazards[J]. Phytotherapy Research, 2020, 34(11): 2932-2944. [63] TANG L, LI SJ, YANG HJ, et al.Autolysis process of neutron body and related enzyme activity changes in mushroom cultivation[J]. Microbial Research(菌物研究), 2021, 19(3): 184-190. [64] HAI LY, ZHI HZ, HUA BZ, et al.Proteomics reveals the mechanism underlying the autolysis of postharvest Coprinus comatus fruiting bodies[J]. Journal of Agricultural and Food Chemistry, 2022, 70(4): 1346-1357. [65] LIU Y, SHI FL, WANG GH.Isolation and identification of natural red pigment from endophytic fungi of Paxillus involutus(Batsch Fr)[J]. Food Research and Development(食品研究与开发), 2021, 42(6): 17-21. [66] LYU JH.Study on chemical constituents and antifungal activities of Paxillus involutus and Phallus rubrovolvatus[D]. Changchun: Jilin Agricultural University, 2022. [67] ZHANG JX, SHUI XX, JIA LF, et al.Extraction optimization and antioxidant activities of ethanol extract of the brown roll-rim mushroom Paxillus involutus (Agaricomycetes)[J]. International Journal of Medicinal Mushrooms, 2023, 25(2): 67-75. [68] LYU JH, YAO L, ZHANG JX, et al.Novel 2,5-diarylcyclopentenone derivatives from the wild edible mushroom Paxillus involutus and their antioxidant activities[J]. Journal of Agricultural and Food Chemistry, 2021, 69(17): 5040-5048. [69] LYU JH, YAO L, LI D, et al.Novel hypoglycemic compounds from wild mushroom Paxillus involutus[J]. Bioorganic Chemistry, 2021, 112: 104984. [70] CHEN ZH, YANG ZL, TU LGE, et al.Poisonous Mushrooms: Recognition and Poisoning Treatment (毒蘑菇识别与中毒防治)[M]. Beijing: Science Press, 2016. [71] LI HJ, ZHANG YZ, ZHANG HS, et al.Mushroom poisoning outbreaks-China, 2023[J]. China CDC Weekly, 2024, 6(4): 64-68. [72] WHITE J, WEINSTEIN AS, HARO DL, et al.Mushroom poisoning: a proposed new clinical classification[J]. Toxicon, 2019, 157: 53-65. [73] SHEN P, SUN DZ, ZHOU W, et al.Research progress in toxicity prediction of traditional Chinese medicines[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2023, 20(4): 473-479. |
[1] | GAO Haiyun, CHEN Yuxin, LI Yao, LI Hui, LIU Tianrui, YUAN Yuan. Herbal textual research and adverse reaction study of Coprinus comatus [J]. Chinese Journal of Pharmacovigilance, 2024, 21(5): 502-506. |
[2] | SU Xiaohan, ZENG Jiao, LI Xue, LIU Lixin, HOU Lingmi, LI Jinsui. Adverse events of abemaciclib in breast cancer patients based on US FAERS database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(5): 580-586. |
[3] | LIU Qi, ZHANG Yufeng, LUO Hao, LI Xin. Analysis of the rationality and safety of clinical application of anrotinib in a hospital [J]. Chinese Journal of Pharmacovigilance, 2024, 21(3): 329-334. |
[4] | WANG Changshun, WANG Xiaolei, DUAN Jiping, YUAN Hao, LIU Yongli, ZHAO Ding. Effect of sulfur fumigation on quality of Angelica dahurica and alternative processing methods in producing areas [J]. Chinese Journal of Pharmacovigilance, 2024, 21(3): 355-360. |
[5] | LI Jiaxin, LIU Huimin, QIAN Wenxiu, MA Ning, SONG Lili, LI Yubo. Nephrotoxic effects and usage of traditional Chinese medicines based on the Traditional Chinese Medicine Systems Toxicology Database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 173-180. |
[6] | ZHU Ying, SHEN Lu, LI Lan, WU Jianmin, GAO Xiaojie. Adverse reaction monitoring of toothpaste in China under the new regulatory system [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 219-222. |
[7] | GAO Yunjuan, ZHAO Xu, BAI Tiankai, BAI Zhaofang, WANG Jiabo, SONG Haibo, XIAO Xiaohe. Discovery and identification strategy for drug safety risks based on big data monitoring of adverse reactions [J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 1-5. |
[8] | ZOU Dongmei, FANG Fang, GUO Yixian, NI Jing, ZHAO Hong, HU Ronghua, SUN Wanling. Analysis of the association of adverse reactions with relative dose of melphalan and body weight in POEMS syndrome patients undergoing melphalan-based ASCT [J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 911-914. |
[9] | JIAO Fuzhi, CHEN Yarui, JI Wei, HAO Jianpeng, GUAN Quanlin. Short-term efficacy and safety evaluation of PD-1 inhibitor combined with chemotherapy as a first-line neoadjuvant therapy for locally advanced gastric adenocarcinoma [J]. Chinese Journal of Pharmacovigilance, 2023, 20(3): 301-305. |
[10] | LI Qianqian, XIA Yan, HOU Tiantian, WANG Chao, SHI Xixi, MA Xuemei, LIU Ziyang, ZHANG Yingli, WU Xiaobing, WANG Sanlong, LIU Guoqing, GENG Xingchao. Nonclinical evaluation of safety of gene therapy drug AAV5 lipoprotein lipase variant (GC304) in the nervous system [J]. Chinese Journal of Pharmacovigilance, 2023, 20(1): 34-39. |
[11] | LIU Zhike, ZHAN Siyan. Progress in applications of self-controlled designs in association study of vaccine safety [J]. Chinese Journal of Pharmacovigilance, 2023, 20(1): 74-78. |
[12] | ZHANG Dousheng, WANG Chen, XU Mingzhe. Rapid evaluation of potential neurotoxicity of levornidazole for injection and its main impurities based on computational models and database technology [J]. Chinese Journal of Pharmacovigilance, 2022, 19(7): 712-716. |
[13] | CUI Can, WEI Hongtao, CHENG Sheng, SHEN Su. Adverse reactions induced by teriparatide [J]. Chinese Journal of Pharmacovigilance, 2022, 19(3): 333-335. |
[14] | LIU Min, PEI Xiaojing, WANG Haixue. Problems with and suggestions about expedited reporting of suspected unexpected serious adverse reactions during clinical trials of drugs in China [J]. Chinese Journal of Pharmacovigilance, 2022, 19(2): 176-179. |
[15] | WU Chen, LIU Cuili, WANG Tao. Cardiovascular safety of haloperidol preparations [J]. Chinese Journal of Pharmacovigilance, 2022, 19(10): 1100-1102. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||